Review
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Pediatr. Nov 8, 2013; 2(4): 36-45
Published online Nov 8, 2013. doi: 10.5409/wjcp.v2.i4.36
Echocardiography in children with Down syndrome
Mohammed A Al-Biltagi
Mohammed A Al-Biltagi, Paediatric Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt
Author contributions: Al-Biltagi M solely contributed to this paper.
Correspondence to: Mohammed A Al-Biltagi, MD, PhD, Associate Professor of Paediatrics, Paediatric Department, Faculty of Medicine, Tanta University, El Bahr Str, Tanta 31527, Egypt. mbelrem@hotmail.com
Telephone: +97-33-9545472 Fax: +20-40-2213543
Received: May 2, 2013
Revised: June 5, 2013
Accepted: June 19, 2013
Published online: November 8, 2013
Processing time: 189 Days and 13.7 Hours
Abstract

Congenital heart disease is a common problem in children with Down syndrome (DS). Echocardiography plays an important role in the detection of both structural and functional abnormalities in this group of patients. Fetal echocardiography can help in the early recognition of DS by detecting soft markers of DS, but its main role is to define the exact nature of the suspected cardiac problem in the fetus. Postnatal echocardiography is mandatory in the first month of life for all neonates with DS. It is also indicated before any cardiac surgery and for serial follow-up after cardiac surgery. In this article, we discuss the types and mechanism of cardiac abnormalities in DS children and the role of both fetal and postnatal echocardiography in the detection of these abnormalities.

Keywords: Fetal; Echocardiography; Congenital heart disease; Down syndrome

Core tip: Cardiac affection is a common issue in the Down syndrome (DS) population, in the form of both congenital and acquired heart disorders. Echocardiography plays an important role in the detection of such disorders. Fetal echocardiography can detect cardiac disorders as early as 10-12 wk of gestation. Echocardiographic examination is recommended for all neonates with DS in the first month of life, before any cardiac surgery, to follow up after cardiac surgery and for serial evaluation of pulmonary hypertension. It is also indicated before involvement in non-cardiac major surgery and before involvement in physical exercise.